![](/img/cover-not-exists.png)
More Subjects Achieved Composite Reductions of ≥1% HbA1C, ≥5% Body Weight and ≥5 mmHg Systolic Blood Pressure with Semaglutide vs. Comparators (SUSTAIN 1–5, 7)
Leiter, Lawrence A., Dungan, Kathleen, Aroda, Vanita R., Knop, Filip Krag, Lausvig, Nanna Leonora, Lindberg, Søren, Meier, JurisVolume:
42
Language:
english
Journal:
Canadian Journal of Diabetes
DOI:
10.1016/j.jcjd.2018.08.016
Date:
October, 2018
File:
PDF, 160 KB
english, 2018